These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1482 related items for PubMed ID: 31521891

  • 1. MiR-143-3p suppresses tumorigenesis in pancreatic ductal adenocarcinoma by targeting KRAS.
    Xie F, Li C, Zhang X, Peng W, Wen T.
    Biomed Pharmacother; 2019 Nov; 119():109424. PubMed ID: 31521891
    [Abstract] [Full Text] [Related]

  • 2. Linc00511 acts as a competing endogenous RNA to regulate VEGFA expression through sponging hsa-miR-29b-3p in pancreatic ductal adenocarcinoma.
    Zhao X, Liu Y, Li Z, Zheng S, Wang Z, Li W, Bi Z, Li L, Jiang Y, Luo Y, Lin Q, Fu Z, Rufu C.
    J Cell Mol Med; 2018 Jan; 22(1):655-667. PubMed ID: 28984028
    [Abstract] [Full Text] [Related]

  • 3. Macrophage-derived exosomal microRNA-501-3p promotes progression of pancreatic ductal adenocarcinoma through the TGFBR3-mediated TGF-β signaling pathway.
    Yin Z, Ma T, Huang B, Lin L, Zhou Y, Yan J, Zou Y, Chen S.
    J Exp Clin Cancer Res; 2019 Jul 15; 38(1):310. PubMed ID: 31307515
    [Abstract] [Full Text] [Related]

  • 4. MicroRNA-323-3p inhibits cell invasion and metastasis in pancreatic ductal adenocarcinoma via direct suppression of SMAD2 and SMAD3.
    Wang C, Liu P, Wu H, Cui P, Li Y, Liu Y, Liu Z, Gou S.
    Oncotarget; 2016 Mar 22; 7(12):14912-24. PubMed ID: 26908446
    [Abstract] [Full Text] [Related]

  • 5. Elevated miR-483-3p expression is an early event and indicates poor prognosis in pancreatic ductal adenocarcinoma.
    Wang C, Sun Y, Wu H, Yu S, Zhang L, Meng Y, Liu M, Yang H, Liu P, Mao X, Lu Z, Chen J.
    Tumour Biol; 2015 Dec 22; 36(12):9447-56. PubMed ID: 26124009
    [Abstract] [Full Text] [Related]

  • 6. MicroRNA-301a-3p promotes pancreatic cancer progression via negative regulation of SMAD4.
    Xia X, Zhang K, Cen G, Jiang T, Cao J, Huang K, Huang C, Zhao Q, Qiu Z.
    Oncotarget; 2015 Aug 28; 6(25):21046-63. PubMed ID: 26019136
    [Abstract] [Full Text] [Related]

  • 7. The miR-217 microRNA functions as a potential tumor suppressor in pancreatic ductal adenocarcinoma by targeting KRAS.
    Zhao WG, Yu SN, Lu ZH, Ma YH, Gu YM, Chen J.
    Carcinogenesis; 2010 Oct 28; 31(10):1726-33. PubMed ID: 20675343
    [Abstract] [Full Text] [Related]

  • 8. Downregulated miR-98-5p promotes PDAC proliferation and metastasis by reversely regulating MAP4K4.
    Fu Y, Liu X, Chen Q, Liu T, Lu C, Yu J, Miao Y, Wei J.
    J Exp Clin Cancer Res; 2018 Jul 03; 37(1):130. PubMed ID: 29970191
    [Abstract] [Full Text] [Related]

  • 9. Role of miR-30a-3p Regulation of Oncogenic Targets in Pancreatic Ductal Adenocarcinoma Pathogenesis.
    Shimomura H, Okada R, Tanaka T, Hozaka Y, Wada M, Moriya S, Idichi T, Kita Y, Kurahara H, Ohtsuka T, Seki N.
    Int J Mol Sci; 2020 Sep 04; 21(18):. PubMed ID: 32899691
    [Abstract] [Full Text] [Related]

  • 10. RELA/NEAT1/miR-302a-3p/RELA feedback loop modulates pancreatic ductal adenocarcinoma cell proliferation and migration.
    Luo Z, Yi ZJ, Ou ZL, Han T, Wan T, Tang YC, Wang ZC, Huang FZ.
    J Cell Physiol; 2019 Apr 04; 234(4):3583-3597. PubMed ID: 30362505
    [Abstract] [Full Text] [Related]

  • 11. Transgelin-2 is a novel target of KRAS-ERK signaling involved in the development of pancreatic cancer.
    Sun Y, Peng W, He W, Luo M, Chang G, Shen J, Zhao X, Hu Y.
    J Exp Clin Cancer Res; 2018 Jul 24; 37(1):166. PubMed ID: 30041673
    [Abstract] [Full Text] [Related]

  • 12. MiR-10b inhibits migration and invasion of pancreatic ductal adenocarcinoma via regulating E2F7.
    Xu C, Qi X.
    J Clin Lab Anal; 2020 Oct 24; 34(10):e23442. PubMed ID: 32592206
    [Abstract] [Full Text] [Related]

  • 13. miR-219-1-3p is a negative regulator of the mucin MUC4 expression and is a tumor suppressor in pancreatic cancer.
    Lahdaoui F, Delpu Y, Vincent A, Renaud F, Messager M, Duchêne B, Leteurtre E, Mariette C, Torrisani J, Jonckheere N, Van Seuningen I.
    Oncogene; 2015 Feb 05; 34(6):780-8. PubMed ID: 24608432
    [Abstract] [Full Text] [Related]

  • 14. MiR-361-3p regulates ERK1/2-induced EMT via DUSP2 mRNA degradation in pancreatic ductal adenocarcinoma.
    Hu J, Li L, Chen H, Zhang G, Liu H, Kong R, Chen H, Wang Y, Li Y, Tian F, Lv X, Li G, Sun B.
    Cell Death Dis; 2018 Jul 24; 9(8):807. PubMed ID: 30042387
    [Abstract] [Full Text] [Related]

  • 15. Deregulation of the MiR-193b-KRAS Axis Contributes to Impaired Cell Growth in Pancreatic Cancer.
    Jin X, Sun Y, Yang H, Li J, Yu S, Chang X, Lu Z, Chen J.
    PLoS One; 2015 Jul 24; 10(4):e0125515. PubMed ID: 25905463
    [Abstract] [Full Text] [Related]

  • 16. Cancer-associated fibroblast-derived exosome Leptin promotes malignant biological lineage in pancreatic ductal adenocarcinoma by regulating ABL2 via miR-224-3p.
    Zhang L, Chen Y, Dai Y, Mou W, Deng P, Jin Y, Xu J, Jin Y.
    Mol Biol Rep; 2024 Sep 19; 51(1):995. PubMed ID: 39298063
    [Abstract] [Full Text] [Related]

  • 17. A novel feedback loop between high MALAT-1 and low miR-200c-3p promotes cell migration and invasion in pancreatic ductal adenocarcinoma and is predictive of poor prognosis.
    Zhuo M, Yuan C, Han T, Cui J, Jiao F, Wang L.
    BMC Cancer; 2018 Oct 23; 18(1):1032. PubMed ID: 30352575
    [Abstract] [Full Text] [Related]

  • 18. Long noncoding RNA TP53TG1 promotes pancreatic ductal adenocarcinoma development by acting as a molecular sponge of microRNA-96.
    Zhang Y, Yang H, Du Y, Liu P, Zhang J, Li Y, Shen H, Xing L, Xue X, Chen J, Zhang X.
    Cancer Sci; 2019 Sep 23; 110(9):2760-2772. PubMed ID: 31325400
    [Abstract] [Full Text] [Related]

  • 19. MiRNA-615-5p functions as a tumor suppressor in pancreatic ductal adenocarcinoma by targeting AKT2.
    Sun Y, Zhang T, Wang C, Jin X, Jia C, Yu S, Chen J.
    PLoS One; 2015 Sep 23; 10(4):e0119783. PubMed ID: 25856297
    [Abstract] [Full Text] [Related]

  • 20. Dysbindin promotes pancreatic ductal adenocarcinoma metastasis by activating NF-κB/MDM2 via miR-342-3p.
    Zhu D, Zheng S, Fang C, Guo X, Han D, Tang M, Fu H, Jiang M, Xie N, Nie Y, Yao X, Chen Y.
    Cancer Lett; 2020 May 01; 477():107-121. PubMed ID: 32120026
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 75.